Eapen, Abey (2018). Recombinant human granulocyte colony stimulating factor for unexplained recurrent miscarriage: A randomised placebo controlled multi-centre study. University of Birmingham. Ph.D.
|
Eapen18PhD.pdf
PDF - Accepted Version Download (1MB) |
Abstract
Immune mediated mechanisms are thought to contribute to recurrent pregnancy losses. A number of treatment options with limited evidence are being used in clinical practice to treat women with recurrent miscarriages.
The objectives of this thesis was
a. To summarise the available evidence for granulocyte colony stimulating factor (G-CSF) in reproductive medicine.
b. To perform a randomised controlled study (RCT) to evaluate the efficacy and safety of recombinant human granulocyte colony stimulating factor (rhG-CSF) in women with unexplained recurrent miscarriages.
The main conclusions from this thesis are:
a. The systematic narrative review found that available evidence is of poor quality, but suggestive of benefit with granulocyte colony stimulating factor in women with recurrent miscarriages.
b. The RCT concluded that administration of rhG-CSF does not improve pregnancy outcomes among women with a history of unexplained recurrent miscarriages. RhG-CSF appears to be safe for both mothers and their offspring/s.
| Type of Work: | Thesis (Doctorates > Ph.D.) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Award Type: | Doctorates > Ph.D. | |||||||||
| Supervisor(s): |
|
|||||||||
| Licence: | ||||||||||
| College/Faculty: | Colleges (2008 onwards) > College of Medical & Dental Sciences | |||||||||
| School or Department: | Institute of Metabolism and Systems Research | |||||||||
| Funders: | Other | |||||||||
| Other Funders: | Birmingham Women’s and Children’s NHS Foundation Trust | |||||||||
| Subjects: | R Medicine > RG Gynecology and obstetrics | |||||||||
| URI: | http://etheses.bham.ac.uk/id/eprint/8297 |
Actions
 |
Request a Correction |
 |
View Item |
Downloads
Downloads per month over past year